T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Quest Diagnostics
DGX
$26B
| $27.3M | ﹤0.01% |
206,897
-8,378
| -4% | -$1.1M |
|
1227
Diageo
DEO
$52.9B
| $27.3M | ﹤0.01% |
142,267
+3,775
| +3% | +$702K |
|
1228
Bath & Body Works
BBWI
$3.89B
| $26.8M | ﹤0.01% |
460,517
-3,350,637
| -88% | -$181M |
|
1229
ON Semiconductor
ON
$32.4B
| $26.8M | ﹤0.01% |
700,453
+8,056
| +1% | +$316K |
|
1230
Cencora
COR
$58.6B
| $26.7M | ﹤0.01% |
233,377
-1,890
| -0.8% | -$223K |
|
1231
Baker Hughes
BKR
$64B
| $26.4M | ﹤0.01% |
1,155,789
+33,134
| +3% | +$765K |
|
1232
Ranpak Holdings
PACK
$477M
| $26.3M | ﹤0.01% |
1,052,186
+1,025,834
| +3,893% | +$21.5M |
|
1233
Blackstone Mortgage Trust
BXMT
$2.46B
| $26.2M | ﹤0.01% |
822,776
-189
| -0% | -$6.08K |
|
|
K
1234
DELISTED
Kellanova
K
| $26M | ﹤0.01% |
431,004
-16,030
| -4% | -$974K |
|
1235
Quantum-Si Incorporated
QSI
$161M
| $25.6M | ﹤0.01% |
+2,194,600
| New | +$23M |
|
|
SWTX
1236
DELISTED
SpringWorks Therapeutics
SWTX
| $25.5M | ﹤0.01% |
308,937
-18,742
| -6% | -$1.42M |
|
|
SIX
1237
DELISTED
Six Flags Entertainment Corp.
SIX
| $25.4M | ﹤0.01% |
586,718
-485,984
| -45% | -$21.9M |
|
1238
Boston Properties
BXP
$11B
| $25.4M | ﹤0.01% |
221,416
-4,080
| -2% | -$458K |
|
1239
Frontdoor
FTDR
$5.94B
| $25.3M | ﹤0.01% |
507,772
-175,481
| -26% | -$9.25M |
|
1240
Arcutis Biotherapeutics
ARQT
$3.2B
| $25.2M | ﹤0.01% |
924,958
+268,537
| +41% | +$7.56M |
|
|
CCC
1241
CCC Intelligent Solutions
CCC
$4.12B
| $25.2M | ﹤0.01% |
2,530,697
+1,419,844
| +128% | +$14.3M |
|
1242
DaVita
DVA
$11.6B
| $25.2M | ﹤0.01% |
209,193
-25,225
| -11% | -$2.99M |
|
|
TBIO
1243
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $25.1M | ﹤0.01% |
911,191
-895,254
| -50% | -$17.6M |
|
1244
Dine Brands
DIN
$434M
| $25M | ﹤0.01% |
280,664
+47,611
| +20% | +$4.41M |
|
1245
Principal Financial Group
PFG
$24.6B
| $25M | ﹤0.01% |
395,030
-1,329,637
| -77% | -$85M |
|
1246
H.B. Fuller
FUL
$3.28B
| $24.8M | ﹤0.01% |
389,933
+83,875
| +27% | +$5.62M |
|
1247
Stepan Co
SCL
$1.47B
| $24.8M | ﹤0.01% |
206,117
-1,084
| -0.5% | -$142K |
|
|
LPRO
1248
DELISTED
Open Lending Corp
LPRO
| $24.8M | ﹤0.01% |
574,554
-163,445
| -22% | -$6.28M |
|
|
FOLD
1249
DELISTED
Amicus Therapeutics
FOLD
| $24.8M | ﹤0.01% |
2,567,676
+482,004
| +23% | +$4.7M |
|
1250
Wabtec
WAB
$50.8B
| $24.6M | ﹤0.01% |
298,667
-3,867
| -1% | -$314K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.